Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients
Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
New approaches to the development of adenoviral dendritic cell vaccines in melanoma
Effect of hyperthermia on the apoptosis and proliferation of CaSki cells
Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?
Hyperthermia as a treatment for bladder cancer
Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells
An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells
NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment
Dendritic cell-based immunotherapy for prostate cancer
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
Palliation of recurrent myxofibrosarcoma with radiotherapy and hyperthermia
Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
The role of hyperthermia in the battle against cancer
[Multidisciplinary therapy for 984 cancer patients–hyperthermic immunotherapy]
RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer